These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9090927)

  • 41. [Study on transdifferentiation of renal tubular cells in rat chronic renal interstitial fibrosis induced by Radix Aristolochiae Fangchi Extract].
    Zhou SJ; Du GY; Zhao Y; Cui HF; Wang XR; Li L; Xiao YQ
    Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(22):1882-5. PubMed ID: 17285990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chinese herbs nephropathy in the Kansai area: a warning report].
    Tanaka A; Shinkai S; Kasuno K; Maeda K; Murata M; Seta K; Okuda J; Sugawara A; Yoshida T; Nishida R; Kuwahara T
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):438-40. PubMed ID: 9198368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aristolochic acids in herbal medicines].
    Sekita S; Kamakura H; Yasuda I; Hamano T; Satake M
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):195-6. PubMed ID: 10097540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common traditional Chinese medicinal herbs for dysmenorrhea.
    Jia W; Wang X; Xu D; Zhao A; Zhang Y
    Phytother Res; 2006 Oct; 20(10):819-24. PubMed ID: 16835873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chinese herbs nephropathy].
    Zhou Y; Li J; Wu X
    Zhong Yao Cai; 2000 May; 23(5):299-300. PubMed ID: 12934599
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs.
    Li M; Au KY; Lam H; Cheng L; But PP; Shaw PC
    Food Chem; 2014 Mar; 147():332-9. PubMed ID: 24206727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Theory of similarity between close relative species of toxic medicinal herbs in toxicity and poisoning action].
    Xie Z; Liang A
    Zhongguo Zhong Yao Za Zhi; 1995 Mar; 20(3):131-4, 190. PubMed ID: 7646772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid.
    Lai MN; Lai JN; Chen PC; Tseng WL; Chen YY; Hwang JS; Wang JD
    Nephrology (Carlton); 2009 Apr; 14(2):227-34. PubMed ID: 19076288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herbal medicines and chronic kidney disease.
    Jha V
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():10-7. PubMed ID: 20586941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephrotoxicity and Chinese Herbal Medicine.
    Yang B; Xie Y; Guo M; Rosner MH; Yang H; Ronco C
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1605-1611. PubMed ID: 29615394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series.
    Chen SP; Tang MH; Ng SW; Poon WT; Chan AY; Mak TW
    Clin Toxicol (Phila); 2010 Oct; 48(8):832-8. PubMed ID: 20969504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.
    Yang CS; Lin CH; Chang SH; Hsu HC
    Am J Kidney Dis; 2000 Feb; 35(2):313-8. PubMed ID: 10676733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chinese herbs nephropathy presentation, natural history and fate after transplantation.
    Reginster F; Jadoul M; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1997 Jan; 12(1):81-6. PubMed ID: 9027778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Query on the cause of "belgium nephropathy" (Chinese herb nephropathy) and the speculation on carcinogenesis of Chinese herbs].
    Li YM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Feb; 22(2):142-5. PubMed ID: 12585157
    [No Abstract]   [Full Text] [Related]  

  • 60. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
    Unger P; Nortier J; Muniz Martinez MC; Plein D; Vandenbossche JL; Vereerstraeten P; Vanherweghem JL
    Nephrol Dial Transplant; 2003 May; 18(5):906-10. PubMed ID: 12686663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.